Discussion of “moral hazard” in The Economist
“Moral Hazard” describes a situation in which the costs of risky behavior are not entirely borne the the actor, but shared with others. Not surprisingly, this encourages risky behavior.
sbecker
Impossible Sums: Costs vs. benefits of the Lockdown, from The Economist 4/25/20
Yes, there are a few benefits!
Microbes and the Metropolis, from the Economist 4/25/20
This isn’t really about architecture – it’s about public health
From the New Yorker: can we control the new coronavirus?
https://www.newyorker.com/magazine/2020/04/13/the-quest-for-a-pandemic-pill
New Yorker article by Nick Paumgarten, on the economic price of the coronavirus
https://www.newyorker.com/magazine/2020/04/20/the-price-of-the-coronavirus-pandemic?utm_source=nl&utm_brand=tny&utm_mailing=TNY_Magazine_042020&utm_campaign=aud-dev&utm_medium=email&bxid=5bea0ba73f92a4046952fe28&cndid=16946854&hasha=3c0d3dd16a7e26d674715f5acb400c8f&hashb=6aab2f3b33f68f0c504d1cefe52f50e3ea133c18&hashc=0dea58d5a2c69bedb496f68872f98c6bd93f8c98e94666a85f5fa8a4f79030ca&esrc=auto_auth_de&utm_term=TNY_Magazine
New Yorker by article by Jill Lepore on pandemics in literature
https://www.newyorker.com/magazine/2020/03/30/what-our-contagion-fables-are-really-about?utm_campaign=aud-dev&utm_source=nl&utm_brand=tny&utm_mailing=TNY_Magazine_032320&utm_medium=email&bxid=5bea0ba73f92a4046952fe28&cndid=16946854&esrc=auto_auth_de&mbid=CRMNYR062419&utm_term=TNY_Magazine
Possible treatment for COVID-19
Monkeys Develop Protective Antibodies to SARS-CoV-2 | The Scientist Magazine® Home / News & Opinion Monkeys Develop Protective Antibodies to SARS-CoV-2 A small study of macaques nds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19. Katarina Zimmer … Read more